PRESS RELEASE published on 05/08/2026 at 06:30, 3 months 10 days ago Lonza Delivers Strong Performance in Q1 2026 in Line with Expectations and Confirms Full-Year Outlook 2026 Lonza delivers strong performance in Q1 2026, confirms outlook for the year. Completes transformation to a pure-play CDMO CDMO Lonza Outlook Transformation Q1 2026
BRIEF published on 04/01/2026 at 06:35, 4 months 17 days ago Lonza annonce les détails de son assemblée générale annuelle 2026 et publie ses rapports 2025. Proposition De Dividende Changements Au Conseil D'administration Efforts De Développement Durable Rapport Annuel 2025 Assemblée Générale Annuelle De 2026
BRIEF published on 04/01/2026 at 06:35, 4 months 17 days ago Lonza Announces 2026 AGM Details and Publishes 2025 Reports Board Changes Dividend Proposal Sustainability Efforts 2025 Annual Report 2026 AGM
PRESS RELEASE published on 04/01/2026 at 06:30, 4 months 17 days ago Lonza Publishes 2026 Annual General Meeting Invitation and 2025 Annual and Sustainability Reports Lonza publishes 2026 AGM invitation and 2025 Annual and Sustainability Reports. Board changes and dividend increase announced Dividend Increase Lonza Annual Report Sustainability Report 2026 AGM
BRIEF published on 03/31/2026 at 14:05, 4 months 18 days ago Lonza nomme Stephen Fry membre indépendant du conseil d'administration Gouvernance Industrie Pharmaceutique Transformation Organisationnelle Conseil D'administration De Lonza Stephen Fry
BRIEF published on 03/31/2026 at 14:05, 4 months 18 days ago Lonza Nominates Stephen Fry as Independent Board Member Pharmaceutical Industry Governance Organizational Transformation Lonza Board Stephen Fry
PRESS RELEASE published on 03/31/2026 at 14:00, 4 months 18 days ago Lonza Nominates Stephen Fry as Independent Board Member Lonza nominates Stephen Fry, with extensive pharma industry track record, as Independent Board Member. Fry to join Lonza AGM in May 2026 Lonza AGM Board Member Pharma Industry Stephen Fry
BRIEF published on 03/09/2026 at 14:05, 5 months 9 days ago Lonza and Genetix Extend Manufacturing Agreement for ZYNTEGLO™ Lonza Gene Therapy Manufacturing Agreement Genetix ZYNTEGLO™
BRIEF published on 03/09/2026 at 14:05, 5 months 9 days ago Lonza et Genetix prolongent leur accord de fabrication pour ZYNTEGLO™ Lonza Thérapie Génique Accord De Fabrication ZYNTEGLO™ Génétique
PRESS RELEASE published on 03/09/2026 at 14:00, 5 months 9 days ago Lonza and Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO™ Lonza and Genetix extend commercial manufacturing agreement for ZYNTEGLO™, the FDA-approved gene therapy for beta-thalassemia patients Lonza Gene Therapy Manufacturing Agreement Genetix ZYNTEGLO
Published on 08/18/2026 at 23:10, 2 hours 43 minutes ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 6 hours 8 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/18/2026 at 18:30, 7 hours 23 minutes ago Sterling Metals Announces Approval of Arrangement by QcX Gold Shareholders
Published on 08/18/2026 at 17:40, 8 hours 13 minutes ago Largo Physical Vanadium Announces Postponement of Annual Meeting
Published on 08/18/2026 at 17:00, 8 hours 53 minutes ago Galaxy Ventures Inc.: TruSilver Deepens 1960s Holes to 712 Metres, Logs Sulphides Next to Past-Producing Walton Silver Mine
Published on 08/18/2026 at 22:00, 3 hours 53 minutes ago Enlight Research publishes updated coverage on Eleving Group
Published on 08/18/2026 at 21:50, 4 hours 3 minutes ago Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
Published on 08/18/2026 at 19:00, 6 hours 53 minutes ago HIAG strengthens sustainable financing with third green bond worth CHF 100 million
Published on 08/18/2026 at 18:45, 7 hours 8 minutes ago Information about Mr. Svetlin Todorov‘s shareholdings in Shelly Group SE
Published on 08/18/2026 at 18:10, 7 hours 43 minutes ago Cumulus Neuroscience Announces Publication in Scientific Reports Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home, Multimodal Cognitive Assessment in People Living with ALS and FTD
Published on 08/18/2026 at 18:00, 7 hours 53 minutes ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 8 hours 8 minutes ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 14 hours 38 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 14 hours 38 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 6 hours ago Aéroports de Paris S.A - July 2026 traffic figures
